Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
J Cardiol
    March 2026
  1. MIYAHARA D, Kida K, Nabeta T, Yoshioka K, et al
    Prognostic value of the clinical phenotype in patients with cardiac sarcoidosis: SARCO phenotype.
    J Cardiol. 2026;87:230-237.
    >> Share

    February 2026
  2. FUJIKI S
    Antiarrhythmic potential of SGLT2 inhibitors: Mechanistic insights and clinical evidence.
    J Cardiol. 2026;87:128-135.
    >> Share

    January 2026
  3. YAGINUMA H, Kitahara H, Suzuki S, Ohno Y, et al
    Prognostic impact of chronic kidney disease in patients with atrial fibrillation after percutaneous coronary intervention.
    J Cardiol. 2026 Jan 6:S0914-5087(25)00323-5. doi: 10.1016/j.jjcc.2025.
    >> Share

    November 2025
  4. SATO H, Takahashi N
    Response to "Contemporary clinical implication of catheter ablation for atrial fibrillation in Japan".
    J Cardiol. 2025 Nov 27:S0914-5087(25)00291-6. doi: 10.1016/j.jjcc.2025.
    >> Share

  5. KANAI M, Yazaki K, Ejima K, Kataoka S, et al
    Prognostic Comparison of Improved versus Preserved Left Ventricular Systolic Function Following Atrial Fibrillation Ablation in Heart Failure Patients.
    J Cardiol. 2025 Nov 20:S0914-5087(25)00281-3. doi: 10.1016/j.jjcc.2025.
    >> Share

    October 2025
  6. TOMITA H, Okumura K
    Current risk stratification schemes for preventing ischemic stroke in patients with nonvalvular atrial fibrillation: HELT-E(2)S(2) and CHA(2)DS(2)-VA scores.
    J Cardiol. 2025 Oct 24:S0914-5087(25)00262-X. doi: 10.1016/j.jjcc.2025.
    >> Share

  7. KATAOKA N, Imamura T
    Contemporary clinical implication of catheter ablation for atrial fibrillation in Japan.
    J Cardiol. 2025 Oct 6:S0914-5087(25)00250-3. doi: 10.1016/j.jjcc.2025.
    >> Share

  8. KAI T, Izumo M, Sekiguchi M, Tanaka T, et al
    Prevalence and clinical outcomes of permanent conduction disturbances after transcatheter aortic valve replacement.
    J Cardiol. 2025;86:395-402.
    >> Share

    September 2025
  9. MATSUNAGA-LEE Y, Egami Y, Ohsuga M, Abe M, et al
    Novel tailored very-high-power short-duration radiofrequency ablation around the esophagus guided by left atrial voltage.
    J Cardiol. 2025;86:249-255.
    >> Share

    August 2025
  10. HASEGAWA K, Stevenson WG
    Antithrombotic Management in Catheter Ablation for ventricular arrhythmias -Mini review.
    J Cardiol. 2025 Aug 21:S0914-5087(25)00210-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  11. WATTANACHAYAKUL P, Yanpiset P, Kulthamrongsri N, Prasitsumrit V, et al
    Prognostic values of atrial high-rate episodes on mortality risks in CIED patients.
    J Cardiol. 2025;86:194-201.
    >> Share

    July 2025
  12. SATO H, Takahashi N
    Temporal and geographical trends in anticoagulant therapy and catheter ablation for atrial fibrillation in Japan, 2014-2022.
    J Cardiol. 2025 Jul 23:S0914-5087(25)00192-3. doi: 10.1016/j.jjcc.2025.
    >> Share

  13. MAO F, Sun Y, Du X, Fu G, et al
    Surface steel ball calibration - A novel method for facilitating fluoroscopic measurement during implantation of WATCHMAN.
    J Cardiol. 2025;86:32-37.
    >> Share

    June 2025
  14. AIZAWA N, Tanno K, Furuya T, Ishinaga T, et al
    Very high-power short-duration ablation for superior vena cava isolation in patients with recurrent atrial fibrillation.
    J Cardiol. 2025 Jun 28:S0914-5087(25)00168-6. doi: 10.1016/j.jjcc.2025.
    >> Share

    May 2025
  15. YAMAGISHI Y, Watabe T, Nakahara D, Taniguchi K, et al
    Characteristics of anxiety about returning to work after implantable cardioverter defibrillator implantation in Japan.
    J Cardiol. 2025 May 30:S0914-5087(25)00143-1. doi: 10.1016/j.jjcc.2025.
    >> Share

  16. AIJAZ A, Magsi IA, Zeeshan I
    Critique on "mitral regurgitation in atrial fibrillation: is a simple repair enough to tackle a complex problem?".
    J Cardiol. 2025 May 27:S0914-5087(25)00135-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  17. EGAMI Y, Kobayashi N, Sugino A, Abe M, et al
    Impact of Sinus Rhythm Maintenance After Repeat Catheter Ablation on Clinical Outcomes in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2025 May 20:S0914-5087(25)00127-3. doi: 10.1016/j.jjcc.2025.
    >> Share

    April 2025
  18. NAKANO T, Oka T, Okayama K, Tanaka N, et al
    Association between oral anticoagulants continuation on thromboembolism and bleeding events in patients with CHADS(2) score 0-2 points after catheter ablation for persistent atrial fibrillation.
    J Cardiol. 2025 Apr 24:S0914-5087(25)00103-0. doi: 10.1016/j.jjcc.2025.
    >> Share

  19. NISHINARITA R, Oikawa J, Arao K, Sugisaki K, et al
    Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation.
    J Cardiol. 2025 Apr 2:S0914-5087(25)00097-8. doi: 10.1016/j.jjcc.2025.
    >> Share

  20. SHINOHARA M, Saji M, Koike H, Ohara H, et al
    Current evidence and indications for left atrial appendage closure.
    J Cardiol. 2025;85:268-274.
    >> Share

    March 2025
  21. OKAJIMA T, Ishikawa S, Uemura Y, Ozaki Y, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure.
    J Cardiol. 2025 Mar 19:S0914-5087(25)00088-7. doi: 10.1016/j.jjcc.2025.
    >> Share

  22. AWAD AK, Elbahloul MA, Gamal A, Attia AN, et al
    Efficacy of surgical ablation and left atrial appendage occlusion in patients with AF undergoing coronary artery bypass grafting: A network meta-analysis.
    J Cardiol. 2025;85:177-185.
    >> Share

  23. KAWAJI T, Hayashi T, Nishimura T, Nagashima K, et al
    3D mapping quest: How far can we see with recent advances in 3D mapping?
    J Cardiol. 2025;85:204-212.
    >> Share

    February 2025
  24. SONG ZQ, Lu XY, Xu YP, Lin H, et al
    Author's reply to "how to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation".
    J Cardiol. 2025 Feb 14:S0914-5087(25)00063-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  25. TALPUR H, Mustafa G
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2025 Feb 13:S0914-5087(25)00059-0. doi: 10.1016/j.jjcc.2025.
    >> Share

  26. ALBAKAA NK, Sato K, Kawamatsu N, Yamamoto M, et al
    Imaging characteristics of patients with cardiac sarcoidosis who presented with ventricular arrhythmias.
    J Cardiol. 2025 Feb 12:S0914-5087(25)00035-8. doi: 10.1016/j.jjcc.2025.
    >> Share

  27. KATAOKA N, Imamura T
    How to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2025 Feb 6:S0914-5087(25)00020-6. doi: 10.1016/j.jjcc.2025.
    >> Share

  28. DIMITRIADIS K, Pyrpyris N, Iliakis P, Kanatas P, et al
    Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?
    J Cardiol. 2025;85:79-87.
    >> Share

  29. WAKAMATSU Y, Nagashima K, Watanabe R, Hirata S, et al
    Beyond the lens: Unveiling the invisible atrioventricular node in the era of high-density mapping.
    J Cardiol. 2025;85:56-62.
    >> Share

    January 2025
  30. BASILE P, Guaricci AI
    Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
    J Cardiol. 2025 Jan 31:S0914-5087(25)00012-7. doi: 10.1016/j.jjcc.2025.
    >> Share

  31. KATAOKA N, Imamura T
    How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts.
    J Cardiol. 2025 Jan 20:S0914-5087(25)00006-1. doi: 10.1016/j.jjcc.2025.
    >> Share

  32. BAZOUKIS G, Hui JMH, Saplaouras A, Efthymiou P, et al
    The impact of new-onset atrial fibrillation in the setting of acute coronary syndrome.
    J Cardiol. 2025 Jan 7:S0914-5087(24)00233-8. doi: 10.1016/j.jjcc.2024.
    >> Share

  33. PASCOE MA, Kolodziej A, Birks EJ, Vaidya G, et al
    Using electronic medical records to identify patients at risk for underlying cardiac amyloidosis.
    J Cardiol. 2025;85:43-44.
    >> Share

    December 2024
  34. KHAN S, Javed R, Amin S
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2024 Dec 12:S0914-5087(24)00226-0. doi: 10.1016/j.jjcc.2024.
    >> Share

  35. KAMADA H, Iriki Y, Yoshimoto I, Ninomiya Y, et al
    Incidence and predictors of persistent iatrogenic atrial septal defect following catheter ablation.
    J Cardiol. 2024;84:372-378.
    >> Share

    October 2024
  36. KOMURO J, Kaneko H, Suzuki Y, Okada A, et al
    Unawareness of being prescribed medications for diabetes and incident cardiovascular disease.
    J Cardiol. 2024;84:294-299.
    >> Share

    September 2024
  37. SONG ZQ, Lu XY, Xu YP, Lin H, et al
    The role of left atrium posterior wall isolation in patients undergoing catheter ablation for atrial fibrillation.
    J Cardiol. 2024 Sep 26:S0914-5087(24)00180-1. doi: 10.1016/j.jjcc.2024.
    >> Share

  38. BASILE P, Monitillo F, Santoro D, Falco G, et al
    Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring.
    J Cardiol. 2024 Sep 13:S0914-5087(24)00177-1. doi: 10.1016/j.jjcc.2024.
    >> Share

  39. MATSUOKA Y, Sotomi Y, Hikoso S, Sunaga A, et al
    Extensive ablation for elderly patients with persistent atrial fibrillation: insights from the EARNEST-PVI prospective randomized trial.
    J Cardiol. 2024 Sep 7:S0914-5087(24)00173-4. doi: 10.1016/j.jjcc.2024.
    >> Share

    August 2024
  40. YOSHII T, Amano M, Moriuchi K, Nakagawa S, et al
    Usefulness of exercise stress echocardiography for predicting cardiovascular events and atrial fibrillation in hypertrophic cardiomyopathy.
    J Cardiol. 2024 Aug 28:S0914-5087(24)00170-9. doi: 10.1016/j.jjcc.2024.
    >> Share

  41. ROMERO CE, Pereira NM, Morales KP, Kerges Bueno BV, et al
    Echocardiographic factors associated with thromboembolic events in patients with cardiac amyloidosis without atrial fibrillation.
    J Cardiol. 2024 Aug 9:S0914-5087(24)00147-3. doi: 10.1016/j.jjcc.2024.
    >> Share

    June 2024
  42. OKISHIGE K, Tachibana S, Shigeta T, Yamauchi Y, et al
    Novel method to avoid serious injurious effects on the atrioventricular nodal (AVN) conduction during catheter ablation of the AVN slow pathway utilizing cryofreezing energy.
    J Cardiol. 2024;83:371-376.
    >> Share

    May 2024
  43. YAMAGUCHI T
    Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective.
    J Cardiol. 2024 May 27:S0914-5087(24)00096-0. doi: 10.1016/j.jjcc.2024.
    >> Share

  44. KURODA S, Kawamura I, Sahashi Y, Kuno T, et al
    The significance of non-sustained ventricular tachycardia on life-threatening ventricular arrhythmia events in patients with non-ischemic cardiomyopathy in the contemporary era: A systematic review and meta-analysis.
    J Cardiol. 2024 May 14:S0914-5087(24)00086-8. doi: 10.1016/j.jjcc.2024.
    >> Share

  45. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
    Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
    J Cardiol. 2024;83:313-317.
    >> Share

    March 2024
  46. BAZOUKIS G, Saplaouras A, Efthymiou P, Yiannikourides A, et al
    Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature.
    J Cardiol. 2024 Mar 31:S0914-5087(24)00053-4. doi: 10.1016/j.jjcc.2024.
    >> Share

  47. IMBURGIO S, Johal A, Akhlaq H, Klei L, et al
    Fatal ventricular arrhythmias in myocarditis: A review of current indications for defibrillator devices.
    J Cardiol. 2024 Mar 27:S0914-5087(24)00054-6. doi: 10.1016/j.jjcc.2024.
    >> Share

    February 2024
  48. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
    Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
    >> Share

    December 2023
  49. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    >> Share

    November 2023
  50. YAMAMOTO T, Nambu Y, Bo R, Morichi S, et al
    Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy.
    J Cardiol. 2023;82:363-370.
    >> Share

  51. NARUMI T, Naruse Y, Miyajima K, Kaneko Y, et al
    Actual conditions of atrial septal lead implantation and the factors related to successful implantation.
    J Cardiol. 2023;82:371-377.
    >> Share

    October 2023
  52. WENG CJ, Li CH, Lin YJ, Chang SL, et al
    Skin Sympathetic Nerve Activity in Different Ablation Settings for Atrial Fibrillation.
    J Cardiol. 2023 Oct 12:S0914-5087(23)00247-2. doi: 10.1016/j.jjcc.2023.
    >> Share

  53. HARA H, Kubo S, Nakajima Y, Matsumoto T, et al
    Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00240-X. doi: 10.1016/j.jjcc.2023.
    >> Share

    September 2023
  54. NAGASE T, Kikuchi T, Unno T, Arai R, et al
    Impedance-guided modified CLOSE protocol ablation can reduce ablation index necessary for pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2023 Sep 7:S0914-5087(23)00224-1. doi: 10.1016/j.jjcc.2023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016